EUCTR2019-001974-27-ESActive, not recruitingPhase 1
Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial [Swiss Trial in solid Organ transplantation on Prevention of inFLUenza] - STOP-F
Centre Hospitalier Universitaire Vaudois (CHUV)0 sites780 target enrollmentStarted: August 9, 2019Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Enrollment
- 780
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
Inclusion Criteria
- •Study participants will be enrolled among =18-year old stable SOT recipients =3 months after transplantation, regularly followed at their respective outpatient clinic at the 7 transplant centers and scheduled to receive the annual influenza vaccine.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 780
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 780
Exclusion Criteria
- •Candidates will be excluded in case of previous severe reaction or allergy to one of the study vaccines or in case of treatment for acute rejection, among others.
Investigators
Similar Trials
Completed
Phase 2
Reducing the Burden of Influenza After Solid-Organ TransplantationOrgan TransplantationInfluenzaNCT03699839Oriol Manuel619
Active, not recruiting
Phase 1
Effictiveness and safety of vaccination with Live-attenuated Influenza VaccineEUCTR2015-003250-41-GBPublic Health England2,500
Recruiting
Phase 4
Prevention and Treatment of Influenza Diseases with Traditional Chinese MedicineInfluenzaITMCTR2100004794anFang Hospital of Southern Medical University
Completed
Not Applicable
Influenza viral shedding after treatment with and anti-influenza drugInfluenzaJPRN-UMIN000046233Japan Physicians Association Influenza Study Group200
Completed
Not Applicable
Influenza viral shedding after treatment with and anti-influenza drugInfluenzaJPRN-UMIN000041188Japan Physicians Association Influenza Study Group300